Reston, VA- Researchers have taken a critical step toward developing a non-invasive nuclear medicine technique that can predict the effectiveness of therapy for cancerous tumors, allowing for personalized, precision treatment. The study is featured in the December issue of The Journal of Nuclear Medicine.
89Zr-immuno-PET is a noninvasive, whole-body imaging technique with the potential to predict the effectiveness of therapeutic antibodies (or their conjugates) in treating tumors. This is a significant advance: currently, the only ways to measure these are through tissue sampling, which is invasive and non-comprehensive, or by measuring concentrations of monoclonal antibodies in blood samples.
To read more please visit:
Source: Society of Nuclear Medicine and Molecular imaging